Basic information
- CAS
1137608-69-5- Standard SMILES
CCOC(=O)[C@@H](N)Cc1ccc(-c2cc(O[C@H](c3ccc(Cl)cc3-n3ccc(C)n3)C(F)(F)F)nc(N)n2)cc1.O=C(O)CNC(=O)c1ccccc1- InChIKey
XSFPZBUIBYMVEA-CELUQASASA-N- Molecular formula
- C36H35ClF3N7O6
- Average molar mass
- 754.2 g/mol
Overview
Telotristat Etiprate is an orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) inhibitor prodrug, with potential antiserotonergic activity. Upon administration, telotristat etiprate is converted to its active moiety, telotristat (LP-778902), which binds to and blocks the activity of TPH. This may result in a reduction in peripheral serotonin (5-HT) production and improvement of serotonin-mediated gastrointestinal effects such as severe diarrhea. TPH, the rate-limiting enzyme in serotonin biosynthesis, is overexpressed in carcinoid tumor cells.
Names & identifiers
- Preferred name
- Telotristat Etiprate
- IUPAC
- 2-benzamidoacetic acid;ethyl (2S)-2-amino-3-[4-[2-amino-6-[(1R)-1-[4-chloro-2-(3-methylpyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]pyrimidin-4-yl]phenyl]propanoate
- English name
- 4-[2-Amino-6-[(1R)-1-[4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]-4-pyrimidinyl]-L-phenylalanine ethyl ester N-benzoylglycine salt
- Molecular formula
- C36H35ClF3N7O6
- Molecular weight
- 754.1546096
Names & synonyms
Show more names
Database identifiers
- CAS
1137608-69-5- PubChem CID
- 25253377
- ChEMBL
CHEMBL3348963- UNII
- 3T25U84H4U
- EC Number
- 812-364-5
Properties
Computed structural properties
- Topological polar surface area
- 198 Ų
- Hydrogen bond donors
- 4
- Hydrogen bond acceptors
- 14
- Rotatable bonds
- 13
- Heavy atoms
- 53
- Formal charge
- 0
- Complexity
- 1,020
Experimental & physicochemical properties
Human Drugs
FDA approved drugs -> Active ingredient
EMA approved medicines: Human medicine (Orphan designations)
FDA approved drugs -> Active ingredient
Physicochemical properties
- storage temp.
- -20 °C, · Store at -20°C, protected from light
- solubility
- 59.33 · DMSO:59.33(Max Conc. mg/mL);78.67(Max Conc. mM)DMSO:PBS (pH 7.2) (1:2):0.33(Max Conc. mg/mL);0.44(Max Conc. mM)DMF:50.0(Max Conc. mg/mL);66.3(Max Conc. mM)Ethanol:5.0(Max Conc. mg/mL);6.63(Max Conc. mM)
- form
- Powder
- color
- White to off-white
- FDA UNII
- 3 T25U84H4U · 3T25U84H4U
- NCI Drug Dictionary
- telotristat etiprate
- Symbol(GHS)
- 7 · GHS07
- Signal word
- Warning
- Hazard statements
- 302 · H302-H315-H319-H335
- Precautionary statements
- 261 · P261-P305+P351+P338
Safety & regulation
GHS classification
Hazard information
Toxicology
Drug Induced Liver Injury
Drug Induced Liver Injury Rank (DILIrank 2.0)
Telotristat etiprate
Ambiguous-DILI-concern
3
Adverse reactions
DOI:10.1016/j.drudis.2016.02.015
Safety data
- Signal word
- Warning
- Symbol(GHS)
- GHS07
- Hazard statements
- H302-H315-H319-H335
- Precautionary statements
- P261-P305+P351+P338
Chemistry & industry
Applications
UsesTelotristat Etiprate is a solid orally bioavailable tryptophan hydroxylase (TPH) inhibitor.
Suppliers102 total
Related reactions
Compound notes
Loading…